Brief: Active Biotech Q4 Operating Loss Narrows To SEK 15.2 Million
Feb 9 (Reuters) - Active Biotech AB publ ACTI.ST :
* Q4 OPERATING LOSS SEK 15.2 MILLION VERSUS LOSS SEK 16.1
MILLION
YEAR AGO
Source text for Eikon: ID:nMFN8bbv2v
Further company coverage: ACTI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))